The ultimate goal is to be able to design precision treatment plans for each patient, principal scientist Michael Pazzani, PhD, said in a Nov. 22 university news release.
“There are a number of drugs for Parkinson’s disease that unfortunately are only about 25 percent effective, but for a certain group of patients they’re 90 percent effective,” he stated. “So if you can understand the relationship between a patient’s genetic background and the drug, then you can tailor a drug to a specific patient or a specific group of patients.”
AI4Health will be located at the USC Information Sciences Institute in Marina del Rey, Calif.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
